Therefore, it is likely that this impairment in the immune system expressed as “uninflamed” TME and characterized by immunological tolerance provokes a weak immunogenicity leading to a poor responsiveness to immunotherapy in patients with EGFR-mutant NSCLC. Here, EGFR is linked to non-small cell lung carcinoma.